This case report describes the successful use of telitacicept, a novel dual inhibitor of B-lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), in a 37-year-old female with SLE-associated PN. The gene discussed is TNFSF13; the disease is poikiloderma with neutropenia.